DUAL ANTIPLATELET THERAPY DE-ESCALATION MODALITIES IN ACUTE CORONARY SYNDROME PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION

被引：0
|
作者：
Greco, Antonio [1 ,2 ]
Laudani, Claudio [1 ,2 ]
Occhipinti, Giovanni [1 ,2 ]
Scalia, Lorenzo [1 ,2 ]
Agnello, Federica [1 ,2 ]
Legnazzi, Marco [1 ,2 ]
Mauro, Maria Sara [1 ,2 ]
Rochira, Carla [1 ,2 ]
Buccheri, Sergio [3 ]
Mehran, Roxana [4 ]
James, Stefan [3 ]
Angiolillo, Dominick [5 ]
Capodanno, Davide [1 ,2 ]
机构：
[1] Univ Catania, Catania, Italy
[2] AOU Policlin G Rodolico San Marco, I-95124 Catania, Italy
[3] Uppsala Univ, Cardiol & Uppsala Clin Res Ctr, Dept Med Sci, Uppsala, Sweden
[4] Icahn Sch Med Mt Sinai, Zena & Michael A Wiener Cardiovasc Inst, New York, NY USA
[5] Univ Florida, Coll Med, Div Cardiol, Jacksonville, FL USA
来源：
EUROPEAN HEART JOURNAL SUPPLEMENTS | 2022年 / 24卷
关键词：
D O I：
10.1093/eurheartjsupp/suac121.517
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
518
引用
收藏
页数：1
相关论文
共 50 条
  • [41] A UK Time Trends Analysis of Dual Antiplatelet Therapy Use and Bleeding in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention
    Mahadevan, Kalaivani
    Harris, Jessica
    Pufulete, Maria
    Johnson, Tom
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2019, 74 (13) : B392 - B392
  • [42] De-Escalation of P2Y12 Receptor Inhibitor Therapy after Acute Coronary Syndromes in Patients Undergoing Percutaneous Coronary Intervention
    Kupka, Danny
    Sibbing, Dirk
    KOREAN CIRCULATION JOURNAL, 2018, 48 (10) : 863 - 872
  • [43] Individualizing Duration of Dual Antiplatelet Therapy After Acute Coronary Syndrome or Percutaneous Coronary Intervention
    Bagai, Akshay
    Bhatt, Deepak L.
    Eikelboom, John W.
    Mancini, G. B. John
    Cohen, Eric A.
    Vijayaraghavan, Ram
    Cheema, Asim N.
    Udell, Jacob A.
    Niznick, Joel
    Tanguay, Jean-Francois
    Verma, Subodh
    Mehta, Shamir R.
    CIRCULATION, 2016, 133 (21) : 2094 - 2098
  • [44] Optimal duration of dual antiplatelet therapy post percutaneous coronary intervention in acute coronary syndrome
    Deharo, Pierre
    Cuisset, Thomas
    TRENDS IN CARDIOVASCULAR MEDICINE, 2020, 30 (04) : 198 - 202
  • [45] Efficacy and Safety of Prolonged Dual Antiplatelet Therapy after Percutaneous Coronary Intervention in Acute Coronary Syndrome Patients
    Han, Jialun
    Zhang, Yi
    Shi, Xiujin
    Lin, Baidi
    Zhang, Yunnan
    Zhang, Ru
    Wang, Yifan
    Yan, Jialin
    Lin, Yang
    GLOBAL HEART, 2023, 18 (01)
  • [46] Optimizing antiplatelet therapy in acute coronary syndrome and percutaneous coronary intervention
    Faxon, David P.
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2012, 79 (02) : 181 - 197
  • [47] Short dual antiplatelet therapy and dual antiplatelet therapy de-escalation after primary percutaneous intervention: For whom and how
    Muthspiel, Marie
    Kaufmann, Christoph C. C.
    Burger, Achim Leo
    Panzer, Benjamin
    Verheugt, Freek W. A.
    Huber, Kurt
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2022, 9
  • [48] De-escalation of antiplatelet treatment after percutaneous coronary interventions for acute coronary syndromes: is less more?
    Varenne, Olivier
    Sinnaeve, Peter R.
    EUROPEAN HEART JOURNAL, 2018, 39 (29) : 2759 - 2761
  • [49] Escalation and De-Escalation of Antiplatelet Therapy after Acute Coronary Syndrome or PCI: Available Evidence and Implications for Practice
    Gragnano, Felice
    Capolongo, Antonio
    Terracciano, Fabrizia
    Gargiulo, Giuseppe
    De Sio, Vincenzo
    Cesaro, Arturo
    Moscarella, Elisabetta
    Patti, Giuseppe
    Porto, Italo
    Esposito, Giovanni
    Angiolillo, Dominick J.
    Calabro, Paolo
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (21)
  • [50] Three Months vs 12-Months Dual Antiplatelet Therapy Duration in Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention
    Selvaraj, Vijairam
    Moustafa, Abdelmoniem
    Bavishi, Chirag
    CIRCULATION, 2021, 144
12345